Brief: T2 Biosystems Receives Extension To Comply With Nasdaq Listing Requirements
31/07/2023 13:58
T2 Biosystems Inc TTOO.O :
* T2 BIOSYSTEMS RECEIVES EXTENSION TO COMPLY WITH NASDAQ
LISTING
REQUIREMENTS
* T2 BIOSYSTEMS - NASDAQ HEARINGS PANEL HAS GRANTED CO'S
REQUEST
FOR EXTENSION THROUGH NOV 20, TO EVIDENCE COMPLIANCE WITH
NASDAQ'S MINIMUM BID PRICE
Source text for Eikon: ID:nGNX6LxsZ1
Further company coverage: TTOO.O
Recent news on T2 Biosystems
See all newsBrief: T2 Biosystems Announces Intent To Wind Down Operations
Brief: T2 Biosystems Enters Amendment No. 12 To Term Loan Agreement
Brief: T2 Biosystems Announces Exclusive US Agreement With Cardinal Health To Sell Its FDA-Cleared Direct-From-Blood Diagnostics For Rapid Detection Of Sepsis-Causing Pathogens
T2 Biosystems Inc reports results for the quarter ended in June - Earnings Summary
Brief: T2 Biosystems Announces Commercial Expansion Through Malaysia And Indonesia Distributor